EnteroMedics (ETRM) Misses Q3 EPS by 5c

EnteroMedics (NASDAQ: ETRM) reported Q3 EPS of ($0.95), $0.05 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $149 thousand versus the consensus estimate of $430 thousand.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c